Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 39 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9458141

    Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted
  2. US 9457132

    Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted
  3. US 9453019

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  4. US 9453239

    Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

    The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  5. US 9452973

    Modulators of the relaxin receptor 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  6. US 9447144

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  7. US 9446048

    Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  8. US 9441022

    Aegyptin and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  9. US 9441050

    High-affinity monoclonal anti-prion antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  10. US 9441019

    Influenza hemagglutinin protein-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  11. US 9439875

    Anxiolytic effect of pterostilbene

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  12. US 9439979

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  13. US 9441041

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  14. US 9441048

    Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  15. US 9427476

    Multivalent meningococcal conjugates and methods for preparing conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  16. US 9428541

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  17. US 9421254

    Immunostimulatory combinations of TLR ligands and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  18. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  19. US 9416190

    Mesothelin antibodies and methods for eliciting potent antitumor activity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  20. US 9415116

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  21. US 9409956

    Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  22. US 9408896

    Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  23. US 9409994

    High-affinity monoclonal antibodies to glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  24. US 9408901

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted